TickerFactsScreenerDevelopers

Black Diamond Therapeutics, Inc. (BDTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$8.90M2019: -$29.33M2020: -$69.57M2021: -$126.87M2022: -$92.83M2023: -$86.46M2024: -$78.78M2025: $12.52M$12.52M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$12.52M+115.9%
2024-$78.78M+8.9%
2023-$86.46M+6.9%
2022-$92.83M+26.8%
2021-$126.87M-82.4%
2020-$69.57M-137.2%
2019-$29.33M-229.4%
2018-$8.90M—